Anesthesic Techniques for Surgery of the Anterior Cruciate Ligament of the Knee in Ambulatory Surgery. Randomized Pilot Monocentric Trial (CLICA)

Surgery of the anterior cruciate ligament of the knee is frequently a young patient surgery. The post-operative pain of this surgery is managed according to recommendation. In the majority of case, femoral nerve block is performed. The femoral nerve block can cause "paralysis" of the quadriceps more or less complete that no allowing a good quadriceps locking. This locking is indispensable to avoid post-operative flexima and to ensure stabilization of the knee during walking.

In France, the surgery requires a duration of hospitalization from 2 to 4 days in the most cases. It is sometimes performed in ambulatory especially in the USA. But, at the home, pain requires powerful analgesics with their adverse events.

Today, no anesthesic technics for surgery of anterior cruciate ligament of the knee ensure in the same time optimal analgesia and optimal quadriceps locking. The main objective of the investigators study is to compare two analgesia techniques : femoral nerve block vs intra articular injection and obturator nerve block in surgery of the anterior cruciate ligament of the knee

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-etienne, France, 42055
        • PASSOT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Physical Status score = 1 or Physical Status score = 2
  • Major Patient
  • indication of anterior cruciate ligament reconstruction
  • informed consent for participation in the study

Exclusion Criteria:

  • Contraindication to general analgesia
  • Contraindication to peripheral nerve block
  • Allergy to analgesic treatment
  • Porphyria,
  • Neurologic deficit
  • Contraindication antiinflammatory drugs
  • Simultaneous reconstruction of another ligament or complex gesture intended
  • Patient treated with an anti-arrhythmic drug class III
  • Patient with severe hepatic impairment
  • Pregnant woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: femoral nerve block
20 ml injection of 2 mg/ml ropivacaine in femoral nerve
2 mg/ml
Experimental: obturator nerve block and intraarticular injection
10 ml injection of 2 mg/ml ropivacaine in obturator nerve intraarticular injection : 10 ml of chlorhydrate ropivacaine (2 mg/ml) and 10ml of magnesium sulfate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of patients with success
Time Frame: 4 postoperative hours
success is defined by : score chung > or egal to 9 and quadriceps locking > or egal to 3/5
4 postoperative hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain for all patients
Time Frame: Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48
pain measured by EVA
Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48
analgesic consumption for all patients
Time Frame: Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48
analgesic consumption of tramadol and morphine (use, number)
Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48
analgesic adverse events for all patients
Time Frame: Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48
Frequency of nausea and vomiting
Postoperative hours : 0, 1, 2, 4, 6, 8, 12, 18, 24, 36 and 48

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sylvie PASSOT, MD, Chu de Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

September 30, 2014

First Submitted That Met QC Criteria

October 2, 2014

First Posted (Estimate)

October 6, 2014

Study Record Updates

Last Update Posted (Estimate)

July 1, 2015

Last Update Submitted That Met QC Criteria

June 30, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 1408021
  • 2014-002062-77 (EudraCT Number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Reconstruction

Clinical Trials on obturator nerve block

Subscribe